眼科領域アレルギー性疾患に対する診断と治療

Size: px
Start display at page:

Download "眼科領域アレルギー性疾患に対する診断と治療"

Transcription

1 allergic conjunctival disorders ACD 1 allergic conjunctivitis AC 2 seasonal allergic conjunctivitis SAC perennial allergic conjunctivitis PAC atopic keratoconjunctivitis AKC 3 AKC AKC vernal keratoconjunctivitis VKC 4 VKC VKC

2 AKC 3 VKC 4 GPC SAC PAC giant papillary conjunctivitis GPC 5 GPC contact lens related papillary conjunctivitis VKC a b GPC VKC GPC 2. AKC atopic dermatitis AD AD VKC AD AD VKC VKC AKC AKC AKC VKC 1. AKC VKC VKC VKC AKC AKC 2. 3 IgE

3 AC 3 4 VKC 3 3 AKC 3 5 GPC a T B Hansel b IgE 10 c P

4 B4ECP IgE IL 4 IL 5 IgE IgE 2 IgE a b IgE 4 2. IgE IgE IgE H A SAC PAC H1 1 H

5 SAC PAC 3 AKC AKC AKC VKC VKC VKC VKC AKC 2. 1 Th12 A2 H1 a. b. c. itching scratching cycle d

6 57 4 e. 2 AKC VKC IgE 5 IgE 2 IgE /3 1/2 Hertoghe Dennie Morgan mediumweak

7 57 4 topical corticosteroid withdrawal syndrome Fleischer ring, keratoconus line acute hydrops

8 57 4 proliferative vitreoretinopathy PVR 16 ultrasound biomicroscope UBM 17 PVR Turf SJ, Kemeny DM, Dart JKG, Buckley RJ Clinical features of atopic keratoconjunctivitis. Ophthalmology , NEW MOOK Asano Kato N, Fukunaga K, Takano Y, Kawakita T, Tsubota K Treatment of atopic blepharitis by controlling eyelids skin water retentionability with creamide gel application. Br J Ophthalmol , IgE Garrity JA, Liesegang JJ Ocular complications of atopic dermatitis. Can J Ophthalmol ,

PAC PAC PAC

PAC PAC PAC PAC PAC PAC + / 398,145,048 411,745,732 13,600,684 24,250,351 25,778,560 1,528,209 4,241,016 3,942,000 299,016 426,636,415 441,466,292 14,829,877 74,000,000 74,000,000 0 74,000,000 74,000,000 0 178,367,442

More information

AC-2

AC-2 AC-1 AC-2 AC-3 AC-4 AC-5 AC-6 AC-7 AC-8 AC-9 * * * AC-10 AC-11 AC-12 AC-13 AC-14 AC-15 AC-16 AC-17 AC-18 AC-19 AC-20 AC-21 AC-22 AC-23 AC-24 AC-25 AC-26 AC-27 AC-28 AC-29 AC-30 AC-31 AC-32 * * * * AC-33

More information

エンジョイ北スポーツ

エンジョイ北スポーツ 28 3 20 85132 http://www.kita-city-taikyo.or.jp 85 63 27 27 85132 http://www.kita-city-taikyo.or.jp 2 2 3 4 4 3 6 78 27, http://www.kita-city-taikyo.or.jp 85132 3 35 11 8 52 11 8 2 3 4 1 2 4 4 5 4 6 8

More information

『こみの株式会社』の実践

『こみの株式会社』の実践 2003 . JA JA A JA 811 2005/8/11 1003 452 10 960 28 2005/8/11 1003 452 6 120 29 2005/8/11 2003 151 10 420 33 2005/8/11 2003 211 3 180 31 2005/8/11 2003 211 3 150 32 827 400 5 80 221 2005/6/25 900 3 300

More information

15 7 26 1,276 3,800 1 16 15 1 2 3 4 2

15 7 26 1,276 3,800 1 16 15 1 2 3 4 2 1 15 7 26 1,276 3,800 1 16 15 1 2 3 4 2 JA 3 4 2 1 3 2001 1981 6 10% 10 30% 1 2 JA JA 2 4 JA 2 1 2 1 2 1 2 1 2 1 2 7 5 1 1 1 3 1 6 1 1 2 2 1 7 2 3 3 53 1 2000 30 8 250 53 435 20 35 3 1 8 2 4 3 2 2 232

More information

EX-word_Library_JA

EX-word_Library_JA JA 2 3 4 5 14 7 1 2 6 3 1 2 7 3 8 27 1 2 3 1 2 3 9 1 2 3 1 2 3 10 12 13 14 11 1 12 1 2 13 1 2 3 25 14 1 2 3 25 15 1 2 3 25 16 1 2 3 25 17 1 2 3 25 18 1 2 3 4 25 19 1 2 3 4 25 20 1 2 21 3 4 25 22 1 2 3

More information

324.pdf

324.pdf 50 50 10 30 11 26 12 27 14 16 27 18 20 21 22 22 22 22 23 24 24 1 No.324 JA 2 85 69 20 12 81 18 12 22 93 10 31 3 50 50 30 30 50 22 27 27 10 16 14 52 10 62 15 64 25 24 50 4 25 23 27 5 10 11 25 6 11 49 10

More information

野岩鉄道の旅

野岩鉄道の旅 29th 5:13 5:34 5:56 6:00 6:12 6:20 6:21 6:25 6:29 6:31 6:34 6:38 6:40 6:45 6:52 6:56 7:01 7:07 7:11 7:32 7:34 7:50 7:58 8:03 8:17 8:36 8:44 5:50 5:54 6:15 6:38 6:39 6:51 6:59 6:59 7:03 7:08 7:08 7:11 7:15

More information

<4D F736F F F696E74202D D322D E63689F18B4C8ED28DA7926B89EF814093FA8AE18140>

<4D F736F F F696E74202D D322D E63689F18B4C8ED28DA7926B89EF814093FA8AE18140> 公益社団法人日本眼科医会第 6 回記者懇談会 花粉症におけるアレルギー性結膜炎 の診断と治療 順天堂大学医学部附属浦安病院眼科海老原伸行 公益社団法人日本眼科医会第 6 回記者懇談会 利益相反開示 海老原伸行 利益相反公表基準に該当なし 1 ( 講演内容 ) 1. 花粉症の疫学と患者さんの QOL 社会的影響 2. 花粉性結膜炎 眼瞼炎の診断と鑑別診断 3. 花粉性結膜炎の治療と予防 その注意点 1998

More information

F 3 12:0013:00 LS

F 3 12:0013:00 LS 3 6 2 1 4F 8:159:15 MS3-1 Dupilumab MS3-2 IL!4/13 Biologic therapydupilumabfor atopic dermatitis 12:0013:00 LS13-1 /B LS13-2 3 6 2 2 4F 3 12:0013:00 LS14 2018 3 6 2 3 4F 2 8:159:15 MS4-1 MS4-2 9:3511:35

More information

Key words : Adverse reactions, Egg allergy, IgG antibody, Mills allergy, FAST

Key words : Adverse reactions, Egg allergy, IgG antibody, Mills allergy, FAST Key words : Adverse reactions, Egg allergy, IgG antibody, Mills allergy, FAST 13) Danaeus, A., Johansson, S. G. O., Foucard, T. & Ohman, S.: Clinical and immunogical aspects of food allergy in childhood.

More information

2) Andrews and Domonkos: Hauseweives' eczma, Disease of the Skin 5 th Ed., Saunders, Philadelphia and London, 69, 19 63. 3) Pillsbury et al.: Dermtitis and Eczema of the Hands, Contact dermatitis, Dermatology,

More information

H1

H1 1 2 3 4 5 6 7 1 2 8 3 4 50Hz 9 10 60Hz 11 12 13 14 15 16 17 EW EW EW KP-J KP-J KP-SJ New New New New New New New New New New 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 New New New New

More information

2-1-2 2-1-3 17 13 30 6 65 60% 2-2

2-1-2 2-1-3 17 13 30 6 65 60% 2-2 2 2-1 2-1-1 0.3 0.3 0.1 1.0 2-1 2-1-2 2-1-3 17 13 30 6 65 60% 2-2 2-3 2-1-4 0.6 0.02 0.2 2-2 2-4 ( ) 2-5 2-6 2-7 2-8 2-9 2-10 1000lx 1 2.1 100lx 1.4 2.7 2-11 lens 2-12 2-13 2-14 2-15 2-3 2-3-1 2-16 2-13

More information

P15 P211 1 P1 P4 P2 P3 P4 P17

P15 P211 1 P1 P4 P2 P3 P4 P17 P15 P211 1 P1 P4 P2 P3 P4 P17 P3 P4 P7 P8 P9 2 1 Q A P17 P17 1 2 3 4 3 5 6 7 8 2 P17 Q A P17 4 1 2 3 4 2 P17 P4 P12 P17 P4 5 5 6 7 8 2 P4 P4 6 1 2 3 4 3 P17 P10 P17 7 5 6 7 8 4 0120-096-991 P17 8 1 2 3

More information

アレルギー性結膜疾患診療ガイドライン(第2版)

アレルギー性結膜疾患診療ガイドライン(第2版) 866 文 1) 日 本 眼 科 医 会 アレルギー 眼 疾 患 調 査 研 究 班 :アル ギー 性 結 膜 疾 患 の 診 断 と 治 療 のガイドライン. 大 野 重 昭 ( 編 ): 日 本 眼 科 医 会 アレルギー 眼 疾 患 調 査 研 究 班 業 績 集. 日 本 眼 科 医 会, 東 京, 9 11, 1995. 2) 内 尾 英 一, 大 野 重 昭 :アレルギー 眼 疾 患 における

More information

研究成果報告書(基金分)

研究成果報告書(基金分) (1) 種類 程度 肥満細胞数の測定と組織でのサ RT-PCR FACS () (1) NMU-/- IgE NMU IgE -/-NMU -/-B IgE NMU -/-B6 IgE NMU NMU CTLMC BMMC IgE NMU CTLMC 13 1. Hayakawa J, Mizukawa Y, Kurata M, Shiohara T: A syringotropic variant

More information

untitled

untitled 5 1.() 2.() 3.(JA ) 2 3 4 5 6 7 8 9 10 11 12 13 1,000m 165.52km2 1,200-1- H15.8.1 1,163 2,121 278 H19.2.1 60 12 8 15 13 4 10 14 4 13 15 16 22 16 12 21 44 81-2- - 0 - - 1 - - 2 - - 3 - - 4 -

More information

広報さがみはら第1242号

広報さがみはら第1242号 LINE UP 3 1 5 6 1 NO.1242 S A G A M I H A R A 1 1 1 16 16 1 6 1 6 1 6 1 1 1 1 1 11 1 1 1 1 1 1 6 1 6 1 1 1 1 1 1 1 1 11 1 1 16 1 1 1 6 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 6 1 16 1 16 1 6 1 1 1 1 1 1

More information

untitled

untitled 1993 2 2.1 2 1 200235 1992 6 7 3 3 84 JA 1990 47.3% 46.5% 1990 31.7% 56.9% 37 6 4 1976 2.2 2.2 1976 1974 1976 1981 1 3.5 1985 60 2005 2006 2006 27 103 522 284 3.5 3.6 2003 109 59.6% 54.1% 31.2% 1970

More information

VOL. 17 NO. 7 CHEMOTHERAPY 1305 1) W. BRumFirr et al. : Clinical and laboratory studies with carbenicillin. Lancet 1: 1289~ 1293, 1967 2) E. T. KNUDSEN et al. : A new semisynthetic penicillin active against

More information

Surface Characterization and Performance of Surface-Treated Materials (II) Container Material Kinji Saijo* *Toyo Kohan Co., LTD Technical Research Laboratory This article reviews the application of surface

More information

2012 10 7,150 8 22 3,159 2,457 78656 21 30 87 330 289 940 456 1450 681 22 60 803 2570 536 1780 251 8 1 2,475 78%2 374 12% 1 342 2 312 3 215 1 1,025 2 753 3 90 1 1,937 612 612 203 136 4 1 2 1,085

More information

16 23 270 5 1 2 3 1 2 3 1 2 3 6 5 54 44 9 9 4,000 118 7 5 JA 8 1 1 2 16 48,000 1 1 1 1 2 2 3 1, 312. 87 4 5 10 3 31 6 10 4 25 7 3 1 2 8 2 495. 84 1 296. 49 2 199. 35 1 124. 62 54. 50 28. 80 34. 17 54.

More information

ACTIVE FOCUS

ACTIVE FOCUS ACTIVE FOCUS Am ACTIVE FOCUS 100% ACTIVE FOCUS 1, m x 4 10-3* 0-4 -4 -.5 x 10-3* 4 0 - - -1.5-1 ACTIVEFOCUS -0.5 0 0.5 mm 1 1.5.5 69.4 1 40.5 100 1, -4 -.5 - -1.5-1 -0.5 0 0.5 mm 1 1.5.5 CPD AcyrSof IQ

More information

- 2 -

- 2 - - 1 - - 2 - - 3 - - 4 - - 5 - - 6 - - 7 - - 8 - - 9 - A) B) C) D) E) F) - 10 - G) H) I) J) P - 11 - 001 1,416,0003/4 1,062,000 002 100,000 50,00023 1,150,000 2,100,000 200,000+ 100,0000.9 1,600,000 JA

More information

名称未設定-3

名称未設定-3 Management with Consideration for the Special Characteristics of Patients with Autistic Disorder in the Dental Setting Hiroshi NAKAGAWA Management of patients with autistic disorder (AD) can be difficult,

More information

KN40_H1H4

KN40_H1H4 NOV 2015 01 Straight Expanded Thread Lead Pitch Tap 02 03 http://www8.cao.go.jp/kourei/whitepaper/w-2013/gaiyou/s1_1.html http://www.mhlw.go.jp/toukei/saikin/hw/jinkou/suii09/deth8.html http://jsco-cpg.jp/guideline/04.html

More information

株式会社ウェッズ

株式会社ウェッズ 39th 1 2 39th 25,000 500 300 20,000 15,000 400 300 200 10,000 5,000 200 100 100 0 0 0 16,000 50 5 12,000 8,000 4,000 40 30 20 10 4 3 2 1 0 0 0 3 4 39th 5 6 39th 7 N E W P R O D U C T S 8 39th 9 10 CO.,LTD.

More information

O-1 O-2 O-3 O-4 O-5 O-6

O-1 O-2 O-3 O-4 O-5 O-6 18 The 18 th Congress of Hokkaido Association for Clinical Engineering Technologists 930940 O-1 O-2 O-3 O-4 O-5 O-6 O-7 O-8 O-9 O-10 O-11 O-12 O-13 O-14 O-15 O-16 O-17 O-18 O-19 O-20 O-21 O-22 O-23 O-24

More information

8 20 symptom free 2 NEJM Clinical Practice fluticasone 1 2 fluticasone IgE 100U/ml 1819 Bostock 1 A Mycobacterium Toxoplasma

8 20 symptom free 2 NEJM Clinical Practice fluticasone 1 2 fluticasone IgE 100U/ml 1819 Bostock 1 A Mycobacterium Toxoplasma The Lancet, vol 378, Dec.17/24/31,2011 Alexander N Greiner USA Peter W Hellings, Guiseppina Rotiroti Glenis K Scadding The Lancet, Dec. 17/24/31, 2011 http://www.allergy.go.jp/allergy/guideline/04/index.html

More information

日本の不動産市場における価格情報とボラティリティの非対称について:大阪市の実証研究から

日本の不動産市場における価格情報とボラティリティの非対称について:大阪市の実証研究から 1 2 3 1. [2001]) 4 2 " " " " DI 3 5 6 7 8 9 10 11 1) * ( ) ( ) ( ) ( ) ( ) ( 1) * ( + + = + + t t r t P t R t P t P t P ρ ) 1 ( * + t ρ 4 PVR [2001] 12 13 14 15 16 17 18 19 20 23 24 25 26 27 ( ) stdev

More information

(印刷)分身主義の森を抜けて‥‥

(印刷)分身主義の森を抜けて‥‥ 2 !? 3 Bunshinism Bunshinism Bunshinism 4 P178 P180 5 *1 *1 *2 *2 ( ) P122!? P37 6 > > > ( ) 7 -------------------- -------------------- 8 P54 9 P180 10 > > > etc. 11 P30 P128!? P216 12 () 13 *3 *3 14

More information

0.02ml IgE RAST MAST CAP 2

0.02ml IgE RAST MAST CAP 2 ( ) 1 0.02ml IgE RAST MAST CAP 2 3 1963 30 4 1986 20 39 IgE 30% 1988 54.7% IgE 47.6% 1990 892 IgE 27% 12% 1995 2379 1995 8 15 1996 1 12 2335 98.5% 2335 24 61 47 44.0 1 1) 2335 613 26.3% 2 5 613 43.4 44.2

More information

好酸球性副鼻腔炎:診断ガイドライン(JESREC Study)

好酸球性副鼻腔炎:診断ガイドライン(JESREC Study) 118 728 2015 : : JESREC Study Japanese Epidemiological Survey of Refractory Eosinophilic Chronic Rhinosinusitis Study : JESREC Study CT NSAIDs CT : JESREC Study JESREC Study 118 729 ph CTMRI Caldwell Luc

More information

P.37 P.816 P.17 P.1819 contents 1 2

P.37 P.816 P.17 P.1819 contents 1 2 201211 NEW! P.37 P.816 P.17 P.1819 contents 1 2 3 4 5 6 7 8 http://www.tokiomarine-nichido.co.jp/ 1 2 16 3 11 4 1 18 9 10 5 6 11 12 18 9 10 6 7 8 13 1411 12 5 13 14 15 1615 16 21 17 18 0120-071-281 19

More information

K. International Preschool Medical Examination Report 健康診断書 1 To be completed by a physician in English if possible. 可能であれば英語でご記入をお願いします Child s name:

K. International Preschool Medical Examination Report 健康診断書 1 To be completed by a physician in English if possible. 可能であれば英語でご記入をお願いします Child s name: K. International Preschool Medical Examination Report 健康診断書 1 To be completed by a physician in English if possible. 可能であれば英語でご記入をお願いします Child s name: Date of birth: / / 診断対象者氏名生年月日 (e.g. Jan./1/1997)

More information

( ) ー ( () ) 250 200 150 100 50 0 51 20 54 59 33 35 91 92 93 98 99 94 6 7 7 8 9 11 18 17 18 20 22 23 10 9 8 9 9 9 62 40 66 74 41 47 21 22 23 24 25 26 10 8 6 4 2 0 m3/s 7 41.3 5 5 18.4

More information

untitled

untitled -35- -36- -37- -38- -39- l l -40- -41- -42- () -43- -44- -45- HWL OP+66.8m 367.05 HWL OP+157.6m HWL OP+238.3m -46- -47- HWL OP+328.8m -48- -49- (12) No.1 No.2 No.3 (13) (12) (12) (12) (14) (12) (12) (12)

More information

untitled

untitled 1 4 4 6 8 10 30 13 14 16 16 17 18 19 19 96 21 23 24 3 27 27 4 27 128 24 4 1 50 by ( 30 30 200 30 30 24 4 TOP 10 2012 8 22 3 1 7 1,000 100 30 26 3 140 21 60 98 88,000 96 3 5 29 300 21 21 11 21

More information

descente-36校了.indd

descente-36校了.indd 皮膚バリア保護的に働く弱酸性ポリエステルを利用した化繊アレルギー原因物質の解明 Investigation of Causes of Clothing Dermatitis - Absorption Test using Weak- Acidic Polyethylene Terephthalate and PET by Ryoji Hirota Kochi Medical School Momoe

More information

DM

DM ( ) FAX DM DM PR 300 - - - - - - - - - - - - - - - - - - 6 3 1 4 3 - - - - PR P173 FAX (2001) (2000) (1999) 1986 http://kimono-yamato.com/04-kiso/qa.html Q&A http://web.sfc.keio.ac.jp/~t00524sh/chousa/rich/kimonobegin.html

More information

東洋医学雑誌

東洋医学雑誌 Vol.61 No.7 924-929, 2010 a b c d Naoki OKADA ad Masaru NATSUAKI b Takashi NISHIMOTO ac Nishimoto Clinic, 2-8-31 Koshienguchi, Nishinomiya, Hyogo 663-8113, Japan Department of Dermatology, Hyogo College

More information

? Circadian Rhythm Circa-dian Rhythm (suprachisamatic nucleus; SCN) 24 24 Rat) Circadian Rhythm (suprachiamatic nucleus; SCN)? (SCN) SCN Suprachiasmatic Nucleus SCN 1. 2. 3. 4. Time lag 1 2

More information

中高齢者の健康・いきいきライフスタイルづくり調査

中高齢者の健康・いきいきライフスタイルづくり調査 1 -- -- 10 11 12 1998-2000 Exercise: A Guide from the National Institute on Aging 1 61-80 26 T PHA Streptoccocal enterotoxin ASEA (IL-2; Th1 ) IL-4Th2 IgE T T - Bcl-2 Fas T PHA SEA IL2 T PHA SEA IL2

More information

fiú‚å−á›Èfi¯‚‰›ï”‘/27-56

fiú‚å−á›Èfi¯‚‰›ï”‘/27-56 2004 16 27 18 521-529 2004 17 1 pp.103-109 2 22 725-732 3 XIV A. B. pp.234-239 4 1 47 1515-1526 5 2 47 1588-1595 6 47 1953-1961 7 XIV. C. pp.240-243 8 XIV. G. pp.251-252 9 XIV. I. pp.255-257 10 XIV. D.

More information

UV UV UV UV UV UV UV UV

UV UV UV UV UV UV UV UV 2 UV UV UV UV UV UV UV UV UV Features Properties Characteristics Features Properties Z-700K-2 Z-700KAG-7 100 0 Z-700K-2 Z-700KAG-7 50 50 Z-700K-2 Z-700KAG-7 0 100 60 Characteristics AG(%) UV UV Features

More information

.K.C.h...C...ren

.K.C.h...C...ren 4 quality of life QOL QOL QOL 3 QOL 19 mmhg 16 mmhg 14 mmhg 1 2 7 20 30 QOL QOL QOL QOL QOL QOL QOL 4 1 1 1 2 1 2 3 1 2 4 2 2 1 2 2 2 2 1 2 3 QOL 3 2 1 1 5 1 1 2 1 Abraham Wise 1 Nd YAG 2 1 200 500 200

More information

第27回角膜カンファランスプログラム

第27回角膜カンファランスプログラム 27 2003 2 20 2 21 2 22 2 20 9 0 0 17 54 01 TLR2 TLR4 ( ( ) 02 mrna Walid Barbour 1 ) 03 P ( 04 IGF-1 P ( 05 ( 06 1 (TG-1) TGF- ( ( 07 ( 08 38MAP ( ( 1 ) Chia-Yang Liu( Winston Kao( 09 XV Dimitri Azar(

More information

untitled

untitled 1 2 3 http://www.info.pmda.go.jp/ 4 5 6 7 8 9 10 11 (Quincke s edema) 12 13 梗 疼 () 14 15 J Allergy Clin Immunol 115;S483-S523, 2005 16 17 IgE IgE IgE 18 19 20 21 腿 22 Hydrocortisone 100 200 mg 5 mg/kg

More information

3 1 1 BCA ACD HP A AB BC ABC ONP x AM, CN x 30 DM DM! CN CN AM AMD 10 1 AB AC

3 1 1 BCA ACD HP A AB BC ABC ONP x AM, CN x 30 DM DM! CN CN AM AMD 10 1 AB AC 3 BCA ACD HP A AB BC ABC ONP x AM, CN x 30 DM DM!CN CN AM AMD 0 AB AC AMD3AMB3030 x x x 0,60,50,30,30 ABCD AC, BD ABD, DBC, BCA, ACD BDA x BDC 80 AB AD ABD sin x sin AD AC ACD sin sin x AC ABC sin AB sin

More information

Atlas_j060419

Atlas_j060419 Hill s Atlas of Veterinary Clinical Anatomy 1 29 30 2 3 4 5 31 32 33 34 35 36 37 6 7 8 9 10 11 12 13 38 39 40 41 14 15 16 17 18 19 20 21 22 23 24 25 26 27 42 43 44 45 46 47 48 49 50 51 52 53 54 55 28 81

More information

10 12 13 16 17 26 26 31 32 33 33 35 37 38 39 42 43 44 2 15 5 15 57 17 16 4 16 4 2 JA 16 7 1 10 22 11 9 12 6 12 2 12 24 17 1 6 JA 3 4 5 16 7 1 6 ( ) ( ) 15 ( ) ( ) ( ) ( ) ( ) 16 3 35 37 1 93 223 ( ) 218

More information